![](https://cdn.sanity.io/images/0vv8moc6/neurolive/5b5d0f4cd402b26569c75fd5b38b251e5ffc72e1-300x300.png?fit=crop&auto=format)
Radiprodil Significantly Reduces Seizure Frequency in Phase 1b Honeycomb Study of GRIN-Related Neurodevelopmental ...
Newly presented data from the phase 1 Honeycomb study (NCT05818943) showed that treatment with investigational radiprodil (GRIN Therapeutics) was generally well tolerated, with significant impacts on seizure frequency in patients with GRIN-related …